Prosiectau (178)
Cardiff University Schools involved in this Project
Evaluation of the efficacy of blocking light below 460 nm in protection from light-induced retinal injury in models of Stargardt's disease (15.05.2024 - 14.05.2025)
- Rozanowska, Malgorzata
Can Nicotinamide protect and restore retinal ganglion cells in a model of autosomal dominant optic neuropathy (OPA1) (04.03.2024 - 03.01.2025)
- Cimaglia, Gloria
Mitochondria in retinal ganglion cell rescue and health (02.01.2024 - 01.01.2025)
- Votruba, Marcela
Improving the genetic prediction of myopia (01.01.2024 - 31.12.2026)
- Guggenheim, Jeremy
Ultracentrifuge for the isolation and purification of nanoparticles, for research into cellular signaling and the development of next-generation therapeutics (01.01.2024 - 31.03.2024)
- Mead, Benjamin
MyoTreat: Myopia - from genes and environment to cellular responses and treatment (01.12.2023 - 30.11.2027)
- Guggenheim, Jeremy
Nicotinamide in Glaucoma (NAMinG): a randomised, placebo-controlled, multicentre, Phase III trial (01.12.2023 - 30.11.2028)
- Morgan, James
RGC structure and mitochondrial function in LHON: the paradox of recovery and an extended therapeutic window (01.10.2023 - 10.10.2026)
- Votruba, Marcela
Spatial transcriptomic profiling to detect cell-specific mechanosensitive mechanisms within human ONHs – a pilot study (04.01.2023 - 03.05.2024)
- Albon, Julie
Nanoscale structural characterisations of ocular tissues derived from human iPS cells (01.01.2023 - 31.12.2025)
- Quantock, Andrew
The CINY-DOX (Cardiff/Irvine/New York-Duke/Osaka/Xiamen) Initiative in Meibomian Gland Research (01.01.2023 - 31.03.2023)
- Quantock, Andrew
The targeted inhibition of microglia for the prevention of retinal ganglion cell damage in glaucoma (01.01.2023 - 31.12.2023)
- Morgan, James
International Partnership Award: Using CRISPR modified embryonic stem cells to generate human 2D retinal organoids (01.12.2022 - 31.03.2023)
- Mead, Benjamin
Commercialisation of clinical eye tracking toolkit (04.10.2022 - 03.01.2023)
- Dunn, Matt J
A preventative approach to ensuring Access to a Sustainable, whole System pathway for older people with vISion impairmenT (ASSIST) (01.10.2022 - 30.09.2024)
- Acton, Jennifer
Exosomes as a therapy for glaucoma (01.10.2022 - 30.09.2025)
- Mead, Benjamin
A prospective natural history study of patients with Autosomal dominant optic atrophy (01.09.2022 - 31.03.2025)
- Mortlock, Katie
Testing of exosome based therapeutics for the eye (01.09.2022 - 30.11.2022)
- Mead, Benjamin
miRNA-mediated therapy for the treatment of glaucoma (01.08.2022 - 31.05.2025)
- Mead, Benjamin
Evaluation of a BDNF ELISA method. (01.07.2022 - 30.06.2023)
- Morgan, James
In vitro assessment (28.04.2022 - 01.02.2023)
- Mead, Benjamin
Scientific advice project (14.01.2022 - 31.05.2022)
- Votruba, Marcela
Novel perimetry for identifying changes in visual field sensitivity in glaucoma (01.12.2021 - 31.10.2025)
- Redmond, Tony
The health economic impact of COVID-19 (01.10.2021 - 30.09.2023)
- Anderson, Philippa
- HEFCW Fund: Examining the assumptions, accuracy and acceptance of an electronic monitoring device for adherence to eye drops: the EASY label study
(31.05.2021 - 30.09.2021)- Morgan, James
Translating myopia genetics discoveries into strategies for early detection and mechanistic insight (30.04.2021 - 29.09.2025)
- Guggenheim, Jeremy
Trauma Aid (01.04.2021 - 31.03.2023)
- Anderson, Philippa
UKRI-COA: A mechanistic understanding of corneal pathobiology and the development and optimization of novel therapeutic strategies (01.04.2021 - 31.07.2021)
- Quantock, Andrew
UKRI:COA The genomic basis of human induced pluripotent stem (iPS) cell differentiation into eye-like tissues (01.04.2021 - 30.09.2021)
- Quantock, Andrew
Infantile nystagmus: Investigating the causes and establishing better measures of visual performance (01.01.2021 - 31.12.2024)
- Erichsen, Jonathan
Development of an eye tracking system for assessment in the home (01.12.2020 - 30.09.2022)
- Erichsen, Jonathan
High fidelity imaging densitometry: exploring the relationship between visual pigment kinetics, choroidal vasculature and sub-retinal drusenoid deposits in age-related macular degeneration (01.10.2020 - 31.03.2024)
- Wood, Ashley
Hospital to Community: identifying the value of community optometrists monitoring and managing chronic eye disease in community practices (01.10.2020 - 28.02.2023)
- North, Rachel
Investigating the effects of brain-derived neurotrophic factor (BDNF) on retinal ganglion cell regeneration/recovery in a mouse model of glaucoma, using platelets as a novel delivery mechanism (01.10.2020 - 30.11.2021)
- Want, Andrew
- Investigating a plausible mechanism underlying hallucinations in Charles
Bonnet Syndrome (01.09.2020 - 30.06.2023)- Dunn, Matt J
Oral glycoside supplement (triterpenoid saponins) for early and intermediate age related macular degeneration (AMD): An exploratory randomised controlled trial (01.08.2020 - 30.09.2024)
- Margrain, Tom
A multidisciplinary approach to early detection and staging disease in glaucoma (01.05.2020 - 31.01.2022)
- Albon, Julie
Functional imaging of the outer retina using high fidelity imaging densitometry: exploring the relationship between visual pigment kinetics and AMD pathology (01.04.2020 - 30.06.2023)
- Wood, Ashley
Stem cell - derived exosomes for the treatment of Glaucoma (01.04.2020 - 30.09.2021)
- Mead, Benjamin
Evaluation of toric flat-pack contact lenses (10.03.2020 - 31.08.2021)
- Terry, Louise
Sustained release formulations for new drugs in the treatment of mitochondrial optic neuropathies (01.02.2020 - 11.02.2022)
- Votruba, Marcela
Evaluation of errors in the delivery of care to patients with eye-related problems (02.01.2020 - 15.09.2023)
- Acton, Jennifer
Oculomotor control and visual perception during pursuit eye movements in the presence infantile nystagmus (01.01.2020 - 30.11.2021)
- Mcilreavy, Lee
The genomic basis of human induced pluripotent stem (iPS) cell differentiation into eye-like tissues (01.11.2019 - 30.09.2024)
- Quantock, Andrew
Targeting NAD+ for retinal ganglion cell protection in experimental glaucoma (01.10.2019 - 30.12.2022)
- Morgan, James
A mechanistic understanding of corneal pathobiology and the development and optimization of novel therapeutic strategies (01.09.2019 - 31.08.2024)
- Quantock, Andrew
Near-infrared light therapy as a therapeutic regimen for inherited optic neuropathy (31.03.2019 - 31.07.2021)
- Votruba, Marcela
Improved eye tracking for MacuMap (01.02.2019 - 31.08.2019)
- Margrain, Tom
Targeted drug delivery to the cornea of the eye via medicated contact lenses and mucoadhesive thin films (01.02.2019 - 28.12.2022)
- Quantock, Andrew
The therapeutic potential of Genipin as a corneal cross-linking agent: Unlocking a new pathway for the treatment of corneal infection and disease (01.02.2019 - 31.01.2022)
- Meek, Keith